市場調查報告書
商品編碼
1284302
到 2028 年的可穿戴機器人外骨骼市場預測 - 按類型(被動外骨骼、動力外骨骼)、最終用戶(工業、軍事和國防、醫療保健、其他最終用戶)、地區劃分的全球分析Wearable Robotic Exoskeleton Market Forecasts to 2028 - Global Analysis By Type (Passive Exoskeletons and Powered Exoskeletons), End User (Industrial, Military and Defense, Healthcare and Other End Users), and Geography |
根據Stratistics MRC,全球可穿戴機器人外骨骼市場預計2022年將達到7587億美元,2028年將達到66.41億美元,複合年增長率為41.4%。
機器人外骨骼是一種可穿戴的機電機器人,由驅動電機、液壓和氣動系統的計算機控制。 它包括使用執行器、算法、傳感器和機械結構執行電機功能的數據收集。 配備機器人外骨骼的專業服務機器人專為提高適應性和安全性而設計。 外骨骼和可穿戴機器人有助於個人移動。 它使癱瘓和中風患者更容易站起來並恢復失去的能力。 外骨骼對工業有很多好處,例如減少與工作相關的事故和疲勞,提高生產力和工作質量。
根據美國心臟協會的數據,超過 650 萬美國人患有中風,預計每年還會增加 795,000 人,其中 60% 的人會出現下肢殘疾。
機器人外骨骼可用於各種環境,包括消費品和軍事應用,以支持人類運動。 人工智能 (Al)、交互式物聯網 (loT)、數字助理、虛擬指導和交互式機器人學習等技術發展改善了物流、醫療和工程行業。 機器人技術領域發生了重大變化,特別是引入了針對機器人優化的人在環優化等技術。 因此,這些都是提振該行業的因素。
機動腿部外骨骼已經取得了長足的進步,但它們在不平坦或光滑的表面上行駛仍然存在問題。 此外,該原型機不支持扭轉運動,這會使攜帶負載旋轉的用戶很快感到疲勞。 這可能會導致不良後果,例如皮膚和組織損傷、骨折等。 為防止市場擴張,監管機構對此類設備製定了特別嚴格的審批程序。
醫療領域對外骨骼設備的需求正在迅速擴大。 其主要原因是先天性身體虛弱患病率上升、機動車事故增加等因素。 軟裝輕型可穿戴機器人外骨骼也被證明是一種創新方式,可以幫助兒童和成人康復,以及維持和恢復老年人的步態。 因此,上述原因正在刺激市場的擴張。
可穿戴機器人和外骨骼已被軍事和醫療保健行業採用。 外骨骼系統已經用於建築等商業行業,以提高工人的生產力和熟練程度。 然而,在商業領域實施該解決方案的相關成本對普通人來說是高得嚇人的。 可穿戴機器人外骨骼市場的發展受到購買這些設備所需的高初始成本的限制。
對於專注於與醫療保健專業人員和行業合作夥伴合作以解決實際臨床挑戰並滿足患者不斷變化的需求的公司而言,這種流行病正在創造巨大的市場前景。 該遠程醫療系統旨在為行動不便的患者提供家庭管理和康復治療。 患者將在臨床醫生的反饋和監測下接受遠程家庭護理。 供應商明白,通過面對面的互動來完成銷售流程是增加收入的唯一途徑。 由於旅行限制和其他鎖定措施,供應商也在努力計劃培訓課程並及時向客戶交貨。
據推測,動力外骨骼因其設計而獲得了有利可圖的增長,這種設計提供背部支撐、感知用戶的動作並向管理齒輪的電機發出信號。 動力外骨骼是由電動機、槓桿、液壓、氣動或這些技術的組合驅動的可穿戴移動設備,可實現更強大、更持久的肢體運動。
醫療保健行業預計在預測期內以最快的複合年增長率增長。 外骨骼產品已廣泛應用於醫療保健行業,用於康復訓練和幫助部分或完全癱瘓的人。 外骨骼在這個行業擁有廣泛的消費群體,加大了新產品的研發投入,為在醫療保健領域佔據主導地位鋪平了道路。
由於越來越多地採用機器人,預計亞太地區在預測期內將佔據最大的市場份額。 韓國和中國因其強大的電子和汽車製造業而成為包括可穿戴機器人在內的機器人技術最重要的市場。 預計該地區在預測期內將快速增長的因素之一是殘疾人人數的增加、研發投資的增加以及醫療保健行業的蓬勃發展。
由於自動化物料搬運的普及,預計歐洲在預測期內的複合年增長率最高。 該地區是一些機械化程度最高的行業的所在地。 該地區的最終用戶部門也是採用尖端技術的領導者。 地方武裝部隊也正在開發部隊外骨骼機器人。 全球範圍內可穿戴機器人市場的增長高度依賴於各種終端用戶業務。
2021 年 7 月,Cyber□□dyne Co., Ltd. 將與 J-Workout Co., Ltd. 建立商業聯盟,並將於 2021 年 8 月起提供新服務。 我們提供“Neuro HALFIT”服務,該服務通過可穿戴機器人 HAL 激活顱神經系統的激活迴路,從而支持運動功能下降患者的功能改善。
2021 年 3 月,Ekso Bionics 與美國生理協會建立了合作夥伴關係,就 EksoNR 外骨骼的臨床療效對醫生進行教育。 該協議將使其他醫生和治療師更加了解 Ekso Bionics 技術以及機器人與康復計劃的適當整合。
According to Stratistics MRC, the Global Wearable Robotic Exoskeleton Market is accounted for $758.7 billion in 2022 and is expected to reach $6,064.1 billion by 2028 growing at a CAGR of 41.4% during the forecast period. Robotic exoskeletons are wearable electromechanical robots controlled by computers that drive motor, hydraulic, and pneumatic systems. It comprises gathering data to perform a motor function by using actuators, algorithms, sensors, and mechanical structures. Professional services robots with robotic exoskeletons are designed to increase adaptability and safety. Exoskeletons and wearable robots facilitate personal mobility. They make it easier for paralysed and stroke victims to stand up and regain lost abilities. Exoskeletons have a number of benefits for the industrial sector, such as a decrease in work-related accidents and fatigue as well as improved productivity and work quality.
According to the American Heart Association, more than 6.5 million Americans have had a stroke, with 795,000 additional cases projected each year, and 60 percent of these people expected to have lower-limb disabilities.
Robotic exoskeletons could be employed in a variety of settings, including consumer goods and military use, to support human motions. The development of technology including artificial intelligence (Al), the interactive internet of things (loT), digital assistants, virtual guidance, and interactive robot learning has improved the logistical, medical, and engineering industries. Due to the introduction of techniques, particularly human-in-the-loop optimisation optimised for robots, the robotics sector has seen significant changes. Therefore, these are the factors causing the industry to rise.
Powered lower-limb exoskeletons have come a long way, but users still have trouble navigating uneven or slippery surfaces. Users turning while carrying goods could quickly become exhausted because the prototypes are not yet capable of handling twisting motions. This can lead to undesirable occurrences including skin and tissue damage and bone fractures. In order to prevent the market from expanding, regulatory agencies have set up a particularly stringent clearance process for such devices.
The need for exoskeleton devices in the medical sector is rapidly expanding. This is mostly caused by the rising prevalence of inherited physical infirmities, rise in auto accidents, and other factors. Additionally, the creation of soft-suit, lightweight wearable robotic exoskeleton has demonstrated to be an innovative method to assist children and adults in rehabilitation as well as the elderly in maintaining or regaining their gait. Therefore, the aforementioned reasons are fueling market expansion.
Wearable robots and exoskeletons are employed in the military and healthcare industries. Exoskeleton systems have already begun to be used in commercial industries like construction to boost worker productivity and proficiency. However, the expense associated with implementing the solutions on the commercial sector is prohibitive for regular people. The wearable robotic exoskeleton market's progress is constrained by the expensive initial cost required to buy these devices.
The epidemic has created significant market prospects for companies that focus on resolving genuine clinical challenges in collaboration with healthcare professionals and industry partners and reacting to patients' evolving needs. This telehealth system is intended to enable patients with mobility impairments home-based management and rehabilitation therapies. Patients will receive remote home care with clinician feedback and monitoring. Suppliers understand that the only way to complete the sales process with in-person interaction is to increase revenue. Vendors also struggle to plan training sessions and make timely deliveries to customers owing to travel restrictions and other lockdown measures.
The powered exoskeletons segment is estimated to have a lucrative growth, due to its design offers back support, senses the user's motion, and sends the signal to motors that manage the gears. A powered exoskeleton is a wearable mobile device that is propelled by electric motors, levers, hydraulics, pneumatics, or a combination of these technologies that allows for stronger and more durable limb movement.
The healthcare segment is anticipated to witness the fastest CAGR growth during the forecast period. Exoskeleton products have become widely available in the healthcare industry, and they are used for rehabilitation training and to assist those who are partially or completely paralysed. Exoskeletons in this industry have a wide consumer base, which has led to increased investments in the research and development of new products, paving the way for the healthcare segment to dominate.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increased adoption of robots across the region. Due of their extensive electronic and automotive manufacturing sectors, South Korea and China are the two most important markets for robotics, including wearable robots. One of the things that is anticipated to ensure that the region grows quicker over the projection period is the rising number of individuals who have disabilities, greater investment on research and development, and the thriving healthcare industry.
Europe is projected to have the highest CAGR over the forecast period, owing to increased use of automated material handling. Some of the most mechanised industries are found in this area. The end-user sectors in the region are also leaders in the adoption of cutting-edge technologies. Exoskeleton robots for troops are also being developed by local militaries. The growth of the wearable robots market on a global scale is significantly influenced by a variety of end-user businesses.
Some of the key players profiled in the Wearable Robotic Exoskeleton Market include Ekso Bionics Holdings Inc., Cyberdyne Inc, Technaid S, Lockheed Martin Corporation, Sarcos Corporation, Honda Motor Co. Ltd, Hocoma AG, ReWalk Robotics Inc., Atoun Inc., Parker Hannifin Corporation, Bionik Laboratories Corporation, Rex Bionics PLC, Bioservo Technologies AB, P & S Mechanics Co.Ltd. and Skelex.
In July 2021, Cyberdyne Inc. has formed a commercial collaboration with J-Workout Inc. to deliver the new service from August 2021. By triggering the activation loop of the brain's nervous system via Wearable Cyborg HAL, the Group delivers Neuro HALFIT as a service to support the functional improvement of patients with decreased motor functions.
In March 2021, Ekso Bionics has established a collaboration with the American Physiatry Society to educate doctors about the clinical benefits of the EksoNR exoskeleton. This agreement will help other physicians & therapists to become more aware of Ekso Bionics technology & a proper integration of robots into rehabilitation programs.